Intended for healthcare professionals

Editorials

Incretins and cancer of the bile duct in type 2 diabetes

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5155 (Published 06 December 2018) Cite this as: BMJ 2018;363:k5155

Linked research

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes